A roadmap to combat Zoonotic Tuberculosis was launched last week at the Union World Conference on Lung Health in Mexico.
In a recent blog by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology, Synpromics is listed as one of 7 prominent players in the UK’s thriving synthetic biology sector.
Over 70 CTLGH members, funders, key stakeholders and collaborators gathered in Edinburgh recently to discuss progress on improving tropical livestock productivity and resilience.
Synpromics is thrilled to announce they have been awarded Best Emerging UK Synthetic Biotech Company at the 9th Annual OBN Awards.
Scientists in Scotland have gained access to the most up-to-date gene sequencing technology, aiding research to better understand human and animal diseases.
University of Edinburgh researchers have contributed to a Zimbabwean initiative to tackle the threat of growing resistance to antibiotics.
A Scottish study that potentially paves the way for the breeding of low-emission livestock has won an internationally respected research prize.
Synpromics Ltd, the leader in gene control, announces a new research partnership with Solid Biosciences and will provide access to a set of key muscle-selective promoter candidates to be used in the development of new treatment options for Duchenne muscular dystrophy (DMD).
Fresh insights into the genetic code of sheep could aid breeding programmes to improve their health and productivity.
Roslin Innovation Centre in Midlothian is at the heart of Scotland’s life sciences industry and has a special focus on animal health, as chief executive John Mackenzie explains in this feature with BQ Scotland.